Jonathan Slonin
Chief Medical Officer · Pacira BioSciences, Inc.
- 2025
- Aug 18, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jonathan Slonin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Shawn Cross - $895K in PCRX purchases and sales in the last 12 months
- Kristen Williams - $498K in PCRX purchases and sales in the last 12 months
- Lauren Riker - $445K in PCRX purchases and sales in the last 12 months
- Mark Froimson - $11K in PCRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jonathan Slonin?
Jonathan Slonin is a corporate insider, tracked as Chief Medical Officer of Pacira BioSciences, Inc. (PCRX). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jonathan Slonin submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jonathan Slonin been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($240K) across all tracked filings.
